| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma (NCT02549638) | Mayo Clinic | 2015-04-08 |
| Safety Study of SEA-CD40 in Cancer Patients (NCT02376699) | Seagen Inc. | 2015-02-28 |
| Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases (NCT02426879) | UMC Utrecht | 2015-02-11 |
| T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer (NCT02133196) | National Cancer Institute (NCI) | 2014-10-23 |
| Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas (NCT02213133) | Karyopharm Therapeutics Inc | 2014-09-22 |
| Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease (NCT02223975) | Gloucestershire Hospitals NHS Foundation Trust | 2014-08-01 |
| Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold (NCT02059252) | Smart Matrix Limited | 2014-08-01 |
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System (NCT02370303) | Mayo Clinic | 2014-08-01 |
| Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly (NCT02151149) | Celgene | 2014-06-09 |
| A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab (NCT02013154) | Leap Therapeutics, Inc. | 2014-05-05 |
| Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma (NCT02131805) | Memorial Sloan Kettering Cancer Center | 2014-05-01 |
| Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients (NCT02095912) | University of Zurich | 2014-03-01 |
| Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design (NCT02128906) | Christopher Wilke | 2013-12-23 |
| Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma (NCT02088515) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2013-12-01 |
| Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study" (NCT01976468) | University of Zurich | 2013-11-01 |
| Nanocytology Test to Evaluate Skin Cancer in High Risk Patients (NCT01905891) | Northwestern University | 2013-07-01 |
| Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma (NCT01794845) | University of Miami | 2013-06-03 |
| Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins (NCT01872130) | Memorial Sloan Kettering Cancer Center | 2013-05-01 |
| Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01592721) | The University of Texas Health Science Center at San Antonio | 2013-04-01 |
| CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT (NCT01760811) | Rabin Medical Center | 2013-01-01 |
| Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment (NCT01666431) | University of Zurich | 2012-06-01 |
| Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology (NCT01540695) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? (NCT01770002) | University of California, Davis | 2012-01-01 |
| Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung (NCT01561456) | Axelar AB | 2011-12-01 |
| Optical Imaging of Head and Neck Cancer (NCT01456143) | Sharmila Anandasabapathy, MD | 2011-12-01 |
| Set-back Suture Versus Traditional Vertical Mattress Suture (NCT01773447) | University of California, Davis | 2011-08-01 |
| Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy (NCT01586767) | Massachusetts General Hospital | 2011-07-12 |
| Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer (NCT01333852) | Lucas Vieira dos Santos | 2011-02-01 |
| Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery (NCT01298167) | Yale University | 2011-02-01 |
| Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer (NCT01161498) | BioVex Limited | 2011-02-01 |
| Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy (NCT01265472) | Rambam Health Care Campus | 2011-01-01 |
| School Response to Families Who Have Children With Cancer (NCT01148082) | Stanford University | 2010-09-01 |
| Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma (NCT01232374) | Biotech Pharmaceutical Co., Ltd. | 2010-09-01 |
| A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer (NCT01208883) | University Hospital, Ghent | 2010-09-01 |
| Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract (NCT01211938) | Gustave Roussy, Cancer Campus, Grand Paris | 2010-06-15 |
| Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial) (NCT00895349) | Ontario Clinical Oncology Group (OCOG) | 2010-04-01 |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) (NCT01077817) | Organon and Co | 2010-02-26 |
| Cetuximab and Lenalidomide in Head and Neck (NCT01133665) | University of Chicago | 2010-02-01 |
| A Phase 1 Study in Participants With Advanced Cancer (NCT01115790) | Eli Lilly and Company | 2010-02-01 |
| Chemoradiation and Panitumumab for Esophageal Cancer (NCT01077999) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-01-01 |
| Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology (NCT03462524) | St. James's Hospital, Ireland | 2010-01-01 |
| Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma (NCT01009203) | New Mexico Cancer Research Alliance | 2009-12-01 |
| Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer (NCT01089803) | University of Minnesota | 2009-09-01 |
| Electronic Brachytherapy for the Treatment of NMSC (NCT01016899) | Xoft, Inc. | 2009-08-01 |
| Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma (NCT00878995) | The University of Texas Medical Branch, Galveston | 2009-06-03 |
| T-cell Based Immunotherapy for Head and Neck Cancer (NCT00937300) | Inge Marie Svane | 2009-06-01 |
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer (NCT01526486) | Emory University | 2009-06-01 |
| Human Papillomavirus on Oral Tissue, Saliva and Serum (NCT01043328) | UPECLIN HC FM Botucatu Unesp | 2009-05-01 |
| An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 (NCT00884520) | Siemens Molecular Imaging | 2009-04-01 |
| Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx (NCT01020097) | Abramson Cancer Center at Penn Medicine | 2009-03-01 |
| Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC (NCT00966472) | Ottawa Hospital Research Institute | 2009-03-01 |
| Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer (NCT00836342) | Massachusetts General Hospital | 2009-02-01 |
| Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy (NCT00707655) | Genmab | 2008-09-01 |
| An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) (NCT00652080) | BPGbio | 2008-06-01 |
| The Impact of Total Body Skin Examination on Skin Cancer Detection (NCT00765193) | Medical University of Graz | 2008-05-01 |
| Sexual Behavior in Head and Neck Cancer Patients (NCT00662662) | M.D. Anderson Cancer Center | 2008-04-01 |
| Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma (NCT00605709) | BPGbio | 2008-03-01 |
| Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer (NCT00573131) | Boston Scientific Corporation | 2008-01-01 |
| The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy (NCT00751543) | National Taiwan University Hospital | 2008-01-01 |
| Effect of the Subconscious on Mohs Micrographic Surgery (NCT00374062) | Northwestern University | 2007-12-01 |
| Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00547157) | Amgen | 2007-11-01 |
| PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) (NCT00446446) | Amgen | 2007-10-30 |
| Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer (NCT00500760) | Amgen | 2007-10-01 |
| Photochemical Tissue Bonding (NCT00586040) | Massachusetts General Hospital | 2007-09-01 |
| Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients (NCT01127737) | Northwestern University | 2007-09-01 |
| Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery (NCT00793169) | Northwestern University | 2007-09-01 |
| Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery (NCT00578214) | Mayo Clinic | 2007-03-01 |
| Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT00443261) | University of Kansas Medical Center | 2007-02-01 |
| MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck (NCT00427102) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-01-01 |
| Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo (NCT00574392) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil (NCT00400205) | Emory University | 2006-08-01 |
| Identification of Key Blood Molecular Markers for Immunotherapy (NCT00507702) | Stanford University | 2006-07-06 |
| Symptom Assessment With Patient Surveys (NCT01135823) | Stanford University | 2006-07-01 |
| Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. (NCT00601185) | Memorial Sloan Kettering Cancer Center | 2006-02-14 |
| Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer (NCT00101582) | Swedish Orphan Biovitrum | 2005-08-01 |
| Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells (NCT01484769) | University of Louisville | 2005-07-01 |
| Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck (NCT00195299) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-04-01 |
| Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer (NCT00364715) | National Taiwan University Hospital | 2005-01-01 |
| Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma (NCT00596219) | Memorial Sloan Kettering Cancer Center | 2003-12-01 |
| Vaccine Treatment for Advanced Non-Small Cell Lung Cancer (NCT00073398) | NewLink Genetics Corporation | 2003-11-01 |
| Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer (NCT00472459) | Galderma R&D | 2003-07-25 |
| Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum (NCT00046189) | National Cancer Institute (NCI) | 2003-04-07 |
| Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer (NCT00197444) | Hamamatsu University | 2003-01-01 |
| Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer (NCT00176267) | Susanne Arnold | 2002-09-01 |
| Laryngeal Preservation in Pyriform Sinus Carcinoma (NCT00770393) | Centre Hospitalier Universitaire de Saint Etienne | 2002-02-01 |
| PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck (NCT00011778) | National Cancer Institute (NCI) | 2001-02-22 |
| Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer (NCT00176254) | Susanne Arnold | 2000-05-01 |
| Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients (NCT00201383) | National Health Research Institutes, Taiwan | 1999-10-01 |
| Optical Biopsy of Human Skin in Conjunction With Laser Treatment (NCT00540566) | University of California, Irvine | 1999-06-01 |
| Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma (NCT00201279) | National Health Research Institutes, Taiwan | 1999-04-01 |
| Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck (NCT00139243) | Dana-Farber Cancer Institute | 1997-10-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00139230) | Dana-Farber Cancer Institute | 1997-01-01 |
| The Effects of Upper Airway and Digestive Tract Tumors on the Immune System (NCT00001603) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 1996-12-01 |
| A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer (NCT00001442) | National Cancer Institute (NCI) | 1995-07-01 |
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole (NCT00038038) | M.D. Anderson Cancer Center | 1994-01-01 |
| Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248) | Leap Therapeutics, Inc. | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva (NCT00426062) | Sheba Medical Center | |